(Q48514864)

12 February 2018

title

Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. (English)

1 reference

12 February 2018

0 references

1 reference

6

Benoit Dawant

1 reference

12 February 2018

author name string

Robert M Kessler

1

1 reference

12 February 2018

M Sib Ansari

2

1 reference

12 February 2018

Patrizia Riccardi

3

1 reference

12 February 2018

Rui Li

4

1 reference

12 February 2018

Karuna Jayathilake

5

1 reference

12 February 2018

Herbert Y Meltzer

7

1 reference

12 February 2018

language of work or name

English

0 references

publication date

31 May 2006

1 reference

12 February 2018

published in

Neuropsychopharmacology

1 reference

12 February 2018

volume

31

1 reference

12 February 2018

issue

9

1 reference

12 February 2018

page(s)

1991-2001

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301108

exact match

0 references

cites work

The family history method using diagnostic criteria. Reliability and validity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Combined 5-HT2/D2 receptor blockade inhibits the firing rate of SNR neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Parametric images of the extrastriatal D2 receptor density obtained using a high-affinity ligand (FLB 457) and a double-saturation method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Clinical research techniques in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Seroquel: electrophysiological profile of a potential atypical antipsychotic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Analysis of emission tomographic scan data: limitations imposed by resolution and background

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Regional selectivity in clozapine treatment?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Prominence of the dopamine D2 short isoform in dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Comparison of methods for analysis of clinical [11C]raclopride studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Multimodality image registration by maximization of mutual information.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Limbic selectivity of clozapine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Multi-modal volume registration by maximization of mutual information

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301108

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301108

1 reference

12 February 2018

PubMed ID

16738543

1 reference

12 February 2018